RGEN Repligen Corporation

$145.81

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Repligen Corporation

Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.

Website: https://www.repligen.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
730272
Address
41 SEYON STREET, BLDG. 1, SUITE 100, BUILDING 1, SUITE 100, WALTHAM, MA, UNITED STATES
Valuation
Market Cap
$7.30B
P/E Ratio
nan
PEG Ratio
2.59
Price to Book
3.70
Performance
EPS
$-0.46
Dividend Yield
—
Profit Margin
-4.02%
ROE
-1.30%
Technicals
50D MA
$142.61
200D MA
$145.31
52W High
$182.52
52W Low
$102.97
Fundamentals
Shares Outstanding
56M
Target Price
$187.60
Beta
1.27

RGEN EPS Estimates vs Actual

● Estimated
● Actual

RGEN News & Sentiment

Sep 22, 2025 • Benzinga SOMEWHAT-BULLISH
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - FactSet Research Systems ( NYSE:FDS ) , Brinker International ( NYSE:EAT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Eddie Kim upgraded Helmerich & Payne, Inc.
Aug 22, 2025 • Benzinga NEUTRAL
Repligen Corporation to Present at Upcoming September Conferences - Repligen ( NASDAQ:RGEN )
WALTHAM, Mass., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Repligen Corporation RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming investor conferences. The Wells Fargo Healthcare Conference, being held September 3 - ...
Aug 22, 2025 • GlobeNewswire NEUTRAL
Repligen Corporation to Present at Upcoming September Conferences
WALTHAM, Mass., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Repligen Corporation ( NASDAQ:RGEN ) , a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming investor conferences.
Aug 20, 2025 • Zacks Commentary NEUTRAL
Do Options Traders Know Something About Repligen Stock We Don't?
Investors need to pay close attention to RGEN stock based on the movements in the options market lately.
Aug 07, 2025 • Zacks Commentary BULLISH
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jul 31, 2025 • Benzinga NEUTRAL
Repligen Stock Outlook: Risk Skewed To The Downside Through 2026 - Repligen ( NASDAQ:RGEN )
Repligen RGEN has been in a steady downtrend for over 1400 days. Adhishthana principles suggest the weakness is likely to continue. Here's a breakdown of the stock's current structure. According to Adhishthana principles, a stock typically breaks out of its Cakra pattern in Phase 9, which starts ...
Sentiment Snapshot

Average Sentiment Score:

0.242
50 articles with scored sentiment

Overall Sentiment:

Bullish

RGEN Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Pre market)
0.02 Surprise
  • Reported EPS: $0.39
  • Estimate: $0.37
  • Whisper: —
  • Surprise %: 6.3%
Feb 19, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.44
  • Estimate: $0.42
  • Whisper: —
  • Surprise %: 5.0%
Nov 12, 2024
Sep 30, 2024 (Pre market)
-0.34 Surprise
  • Reported EPS: $-0.01
  • Estimate: $0.33
  • Whisper: —
  • Surprise %: -103.5%
Jul 30, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.33
  • Whisper: —
  • Surprise %: 0.0%
May 01, 2024
Mar 31, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.30
  • Whisper: —
  • Surprise %: -6.7%
Feb 21, 2024
Dec 31, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.33
  • Whisper: —
  • Surprise %: 0.0%
Oct 31, 2023
Sep 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $0.23
  • Estimate: $0.17
  • Whisper: —
  • Surprise %: 35.3%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.48
  • Whisper: —
  • Surprise %: 10.4%
May 02, 2023
Mar 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.64
  • Estimate: $0.59
  • Whisper: —
  • Surprise %: 8.5%

Financials